UNLIMITED TURBO SHORT - PFIZER INC | Market Closed - Euronext Paris 10:00:01 15/05/2024 pm IST | ||
| 3.83 EUR | -14.51% |
|
| Current month | -45.67% | ||
| 1 month | -43.49% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 15/24/15 | 3.83 | -14.51% |
| 14/24/14 | 4.48 | +1.82% |
| 13/24/13 | 4.4 | -6.38% |
| 10/24/10 | 4.7 | -3.29% |
| 09/24/09 | 4.86 | -0.61% |
Real-time Euronext Paris
Last update May 15, 2024 at 10:00 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | 
BNP Paribas
|
| MY5MB | |
| ISIN | NLBNPNL2LKG3 |
| Date issued | 15/12/2023 |
| Strike | 32.78 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 6.13 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.81 € |
|---|---|
| Lowest since issue | 3.21 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.38
USD
Average target price
31.94
USD
Spread / Average Target
+12.54%
- Stock Market
- Certificates
- MY5MB Certificat
